Assessment of Fecal Markers and Clinical Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results from PURSUIT-SC Induction

被引：0

作者：

Sandborn, William ^{[1
]}

Feagan, Brian ^{[2
]}

Marano, Colleen ^{[3
]}

Strauss, Richard ^{[3
]}

Johanns, Jewel ^{[3
]}

Zhang, Hongyan ^{[3
]}

Colombel, Jean-Frederic ^{[4
]}

Reinisch, Walter ^{[5
,6
]}

Gibson, Peter ^{[7
]}

Collins, Judith ^{[8
]}

Tarabar, Dino ^{[9
]}

Hebzda, Zbigniew ^{[10
]}

Rutgeerts, Paul ^{[11
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

[2] Robarts Res Inst, London, ON N6A 5C1, Canada

[3] Janssen R&D LLC, Spring House, PA USA

[4] CHU Lille, F-59037 Lille, France

[5] McMaster Univ, U Innere Med 3, Vienna, Austria

[6] McMaster Univ, U Innere Med 3, Hamilton, Austria

[7] Alfred Hosp, Melbourne, Vic, Australia

[8] Oregon Hlth & Sci Univ, Portland, OR USA

[9] Mil Med Acad, Belgrade 11002, Serbia

[10] Klin Chorob Wewnetrznych, Krakow, Poland

[11] U Hosp, Leuven, Belgium

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷

关键词：

D O I：

10.14309/00000434-201410002-01700

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1700

引用

页码：S502 / S503

页数：2

共 50 条

[1] Clinical Outcomes in Continuous Clinical Responders with Moderately to Severely Active Ulcerative Colitis: Subanalyses from the PURSUIT-SC Maintenance Study
Sandborn, William
Colombel, Jean-Frederic
Reinisch, Walter
Gibson, Peter
Feagan, Brian
Marano, Colleen
Strauss, Richard
Johanns, Jewel
Zhang, Hongyan
Weng, Haoling
Yao, Ruji
Tarabar, Dino
Hebzda, Zbigniew
Rutgeerts, Paul
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S505 - S505
[2] Effects of Immunomodulators on the Pharmacokinetics and Efficacy of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT-SC Induction and Maintenance Studies
Adedokun, Omoniyi
Xu, Zhenhua
Marano, Colleen
Strauss, Richard
Zhang, Hongyan
Johanns, Jewel
Ford, Joyce
Zhou, Honghui
Davis, Hugh
Colombel, Jean-Frederic
Reinisch, Walter
Feagan, Brian
Rutgeerts, Paul
Sandborn, William
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S517 - S517
[3] Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension
Reinisch, Walter
Gibson, Peter R.
Sandborn, William
Feagan, Brian G.
Marano, Colleen
Strauss, Rick
Johanns, Jewel
Zhang, Hongyan
Padgett, Lakshmi
Adedokun, Omoniyi J.
Colombel, Jean-Frederic
Collins, Judith
Rutgeerts, Paul J.
Tarabar, Dino
GASTROENTEROLOGY, 2016, 150 (04) : S776 - S777
[4] Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the PURSUIT-SC Maintenance Study Extension
Gibson, Peter R.
Reinisch, Walter
Sandborn, William
Feagan, Brian G.
Marano, Colleen W.
Strauss, Richard
Johanns, Jewel
Zhang, Hongyan
Padgett, Lakshmi
Colombel, Jean-Frederic
Collins, Judith
Rutgeerts, Paul J.
GASTROENTEROLOGY, 2014, 146 (05) : S587 - S587
[5] Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension
Reinisch, W.
Gibson, P.
Sandborn, W. J.
Feagan, B. G.
Marano, C.
Strauss, R.
Johanns, J.
Zhang, H.
Padgett, L.
Colombel, J. -F.
Collins, J.
Rutgeerts, P.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S6 - S7
[6] Safety, efficacy, and pharmacokinetics of golimumab in patients with moderately to severely Active ulcerative colitis: PURSUIT-SC long-term extension
Reinisch, W.
Gibson, P.
Sandborn, W. J.
Feagan, B.
Marano, C.
Strauss, R.
Johanns, J.
Zhang, H.
Padgett, L.
Adedokun, O. J.
Colombel, J. -F.
Collins, J.
Rutgeerts, P.
Tarabar, D.
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S248 - S249
[7] Impact of Golimumab SC on Disease Specific and Generic HRQoL in Patients With Moderately to Severely Active UC: PURSUIT-SC Induction
Feagan, Brian
Gibson, Peter
Marano, Colleen
Strauss, Richard
Han, Chenglong
Johanns, Jewel
Zhang, Hongyan
Guzzo, Cynthia
Colombel, Jean-Frederic
Reinisch, Walter
Collins, Judith
Jarnerot, Gunnar
Rutgeerts, Paul
Sandborn, William
INFLAMMATORY BOWEL DISEASES, 2012, 18 : S43 - S43
[8] Early Responses in Patient-reported Outcomes Are Predictors for Mucosal Healing in Patients with Moderately to Severely Active Ulcerative Colitis Treated with Golimumab: Results from PURSUIT SC Induction
Sandborn, William
Reinisch, Walter
Feagan, Brian
Marano, Colleen
Strauss, Richard
Han, Chenglong
Johanns, Jewel
Zhang, Hongyan
Gibson, Peter
Collins, Judith
Jarnerot, Gunnar
Rutgeerts, Paul
Colombel, Jean-Frederic
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S519 - S519
[9] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Reinisch, Walter
Sandborn, William J.
Hommes, Daniel W.
D'Haens, Geert R.
Hanauer, Stephen B.
Schreiber, Stefan
Panaccione, Remo
Fedorak, Richard N.
Tighe, Mary Beth
Huang, Bidan
Lazar, Andreas
GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
[10] Characterization of Molecular Response to Golimumab in Ulcerative Colitis by mRNA Expression Profiling: Results From Pursuit-SC Induction Study
Li, Katherine
Telesco, Shannon
Rutgeerts, Paul J.
Sandborn, William
Marano, Colleen W.
Ma, Keying
Johanns, Jewel
Zhang, Hongyan
Strauss, Richard
Reinisch, Walter
Colombel, Jean-Frederic
Brodmerkel, Carrie
GASTROENTEROLOGY, 2013, 144 (05) : S465 - S466

← 1 2 3 4 5 →